Drug Delivery and Glaucoma: Dextenza for Xen Patients

Show Description +

I. Paul Singh, MD, shares an example of one patient of a case series of 10 patients in which he has placed a Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) in the inferior and superior canaliculus for patients after Xen Gel Stent (Allergan) implantation.

Posted: 10/10/2022

Drug Delivery and Glaucoma: Dextenza for Xen Patients

I. Paul Singh, MD, shares an example of one patient of a case series of 10 patients in which he has placed a Dextenza (dexamethasone ophthalmic insert 0.4 mg, Ocular Therapeutix) in the inferior and superior canaliculus for patients after Xen Gel Stent (Allergan) implantation.

Posted: 10/10/2022

Please log in to leave a comment.

More in Glaucoma

Academy IRIS® Registry Data Outcomes on Gel Stent Use

Arsham Sheybani, MD

A Monocular Patient With Significant OSD and Worsening Visual Acuity

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO

Excimer Laser Treatment for Open-Angle Glaucoma

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Mark J. Gallardo, MD

Angle-Based MIGS for a Patient With Severe Glaucoma

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO